Parke-Davis

Parke-Davis. It was an American pharmaceutical company, among the oldest and largest in the United States during the late 19th and early 20th centuries. Founded in Detroit, the firm pioneered modern methods of drug standardization, research, and mass production. Its extensive product portfolio included landmark medicines, vaccines, and ethical pharmaceuticals before its eventual absorption into larger corporate entities.

History

The company was established in 1866 by physician Hervey C. Parke and pharmacist George S. Davis as Parke, Davis & Company. An early partnership with William R. Warner, another prominent Philadelphia drug manufacturer, helped expand its operations. Under the scientific leadership of figures like Francis E. Stewart, the company established one of the first modern industrial research laboratories in the United States. This facility in Detroit became a global model, attracting visits from international scientists and cementing the firm's reputation for innovation. Parke-Davis grew rapidly, establishing manufacturing plants and sales offices worldwide, including significant operations in Hounslow, England, and Bombay, India.

Products and innovations

Parke-Davis was responsible for numerous therapeutic breakthroughs and was a major producer of biological products. It developed and mass-produced the first reliable antitoxin for diphtheria in the 1890s, a critical advance in public health. The company's researchers, including Jokichi Takamine, isolated adrenaline (epinephrine), marking the first time a pure hormone was obtained from the adrenal gland. It was an early and prolific manufacturer of insulin following its discovery at the University of Toronto. Other significant products included the anticonvulsant Dilantin (phenytoin), the antibiotic Chloromycetin (chloramphenicol), and the early influenza vaccine. The firm also produced a wide range of tinctures, elixirs, and patent medicines like Pertussin cough syrup.

Legal and ethical controversies

The company's history includes several notable legal and ethical challenges. In the early 20th century, it was implicated in the development and testing of pharmaceuticals on vulnerable populations. Most infamously, from 1955 to 1957, Parke-Davis contracted with the Ohio Department of Mental Hygiene to conduct drug trials on residents of the Columbus State School. These experiments, involving the anticonvulsant Dilantin and other drugs on children with intellectual disabilities, were later criticized as unethical. In the 1990s, after becoming part of Warner-Lambert, the company faced major litigation and a guilty plea for illegal off-label marketing of the anticonvulsant Neurontin (gabapentin), resulting in one of the largest healthcare fraud settlements of that era.

Acquisition and legacy

Parke-Davis's independence ended in 1970 when it was acquired by Warner-Lambert, a conglomerate that itself had origins in the Warner partnership. This merger created a pharmaceutical giant, with Parke-Davis's research division remaining productive, notably co-developing the blockbuster cholesterol-lowering drug Lipitor (atorvastatin) with Pfizer. In 2000, Pfizer acquired Warner-Lambert in a hostile takeover, primarily to gain full control of Lipitor. The Parke-Davis name was gradually phased out, though it persisted on some legacy products and manufacturing facilities. The historic Detroit research and administration complex, known as the Parke-Davis Research Laboratory, is listed on the National Register of Historic Places.

Corporate identity and facilities

The company's original headquarters and main plant were located on the Detroit River, becoming a massive complex that functioned as a self-contained "industrial city". Its iconic administrative building, designed by architects Smith, Hinchman & Grylls, featured a distinctive clock tower that was a local landmark. Parke-Davis also operated major manufacturing facilities in Rochester, Michigan; Greenville, South Carolina; and Holland, Michigan. The company maintained an extensive global presence with subsidiaries like Parke-Davis & Company in Bombay and Parke, Davis & Company in Hounslow. Its corporate logo, often featuring the initials P-D, was widely recognized in medical communities worldwide, symbolizing its long-standing position at the forefront of the pharmaceutical industry.

Category:Pharmaceutical companies of the United States Category:Companies based in Detroit Category:Defunct pharmaceutical companies